Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

In-hospital versus after-discharge complete revascularization in patients with ST segment elevation myocardial infarction and multivessel disease. REVIVA-ST trial.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • المصدر:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: San Francisco, CA : Public Library of Science
    • الموضوع:
      ST Elevation Myocardial Infarction*/surgery ; Patient Discharge* ; Percutaneous Coronary Intervention*/methods ; Length of Stay*; Humans ; Male ; Female ; Middle Aged ; Aged ; Myocardial Revascularization/methods ; Hospitalization ; Coronary Artery Disease/surgery ; Treatment Outcome
    • نبذة مختصرة :
      Introduction: Complete revascularization (CR) in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease (MVD), is associated with a reduction in major adverse cardiovascular events (MACE). However, there is uncertainty about whether nonculprit-lesion revascularization should be performed, during index hospitalization or delayed, especially regarding health care resources utilization. In this study, we aimed to evaluate the impact of in-hospital nonculprit-lesion revascularization vs. delayed (after discharge) revascularization on the length of index hospitalization.
      Methods: In this single-center study, we randomly assigned patients with STEMI and MVD who underwent successful culprit-lesion PCI to a strategy of either CR during in-hospital admission or a delayed CR after discharge. The first primary endpoint was the length of hospital stay. The second endpoint was the composite of cardiovascular death, myocardial infarction or ischemia-driven revascularization at 12 months (MACE).
      Results: From January 2018 to December 2022, we enrolled 258 patients (131 allocated to CR during in-hospital admission and 127 to an after-discharge CR). We found a significant reduction in the length of hospital stay in those assigned to after-discharge CR strategy [4 days (3-5) versus 7 days (5-9); p = 0.001]. At 12-month of follow-up, no differences were found in the occurrence of MACE, 7 (5.34%) patients in in-hospital CR and 4 (3.15%) in after-discharge CR strategy; (hazard ratio, 0.59; 95% confidence interval, 0.17 to 2.02; p = 0.397).
      Conclusions: In STEMI patients with MVD, an after-discharge CR strategy reduces the length of index hospitalization without an increased risk of MACE after 12 months of follow-up.
      Trial Registration: ClinicalTrials.gov number: NCT04743154.
      Competing Interests: The authors have declared that no competing interests exist.
      (Copyright: © 2024 Rumiz et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
    • References:
      EuroIntervention. 2024 Feb 05;20(3):e171-e173. (PMID: 38343368)
      Lancet. 2003 Jan 4;361(9351):13-20. (PMID: 12517460)
      J Am Coll Cardiol. 2015 Mar 17;65(10):963-72. (PMID: 25766941)
      Eur Heart J. 2019 Jan 14;40(3):237-269. (PMID: 30165617)
      Am J Cardiol. 2015 Oct 15;116(8):1157-62. (PMID: 26282725)
      Eur Heart J. 2023 Oct 12;44(38):3720-3826. (PMID: 37622654)
      N Engl J Med. 2013 Sep 19;369(12):1115-23. (PMID: 23991625)
      Lancet. 2023 Apr 8;401(10383):1172-1182. (PMID: 36889333)
      Cardiol Clin. 2020 Nov;38(4):491-505. (PMID: 33036712)
      Coron Artery Dis. 2009 Sep;20(6):415-21. (PMID: 19641460)
      JAMA Cardiol. 2019 Aug 1;4(8):736-744. (PMID: 31268466)
      Lancet. 2015 Aug 15;386(9994):665-71. (PMID: 26347918)
      Eur Heart J. 2018 Jan 7;39(2):119-177. (PMID: 28886621)
      Eur Heart J. 2007 Jul;28(14):1709-16. (PMID: 17556348)
      Heart. 2010 May;96(9):662-7. (PMID: 19778920)
      N Engl J Med. 2019 Oct 10;381(15):1411-1421. (PMID: 31475795)
      N Engl J Med. 2017 Mar 30;376(13):1234-1244. (PMID: 28317428)
      Am Heart J. 2004 Sep;148(3):467-74. (PMID: 15389234)
      N Engl J Med. 2023 Oct 12;389(15):1368-1379. (PMID: 37634190)
    • Molecular Sequence:
      ClinicalTrials.gov NCT04743154
    • الموضوع:
      Date Created: 20240514 Date Completed: 20240514 Latest Revision: 20240612
    • الموضوع:
      20240613
    • الرقم المعرف:
      PMC11093342
    • الرقم المعرف:
      10.1371/journal.pone.0303284
    • الرقم المعرف:
      38743727